|
Dabigatran, n=32 |
Warfarin, n=31 |
p-value |
Primary |
Primary |
Primary |
Primary |
Dementia diagnosis |
0 (0%) |
0 (0%) |
— |
Cognitive impairment |
5 (15.6%) |
2 (6.5%) |
0.23 |
ADAS >30% increase |
5 (15.6%) |
2 (6.5%) |
0.23 |
DAD >30% decrease |
0 (0%) |
0 (0%) |
— |
DAD >50% incorrect |
0 (0%) |
0 (0%) |
— |
Secondary |
Secondary |
Secondary |
Secondary |
Stroke or TIA |
2 (4.0%) |
0 (0%) |
0.24 |
Stroke |
0 (0%) |
0 (0%) |
— |
TIA |
2 (4.0%) |
0 (0%) |
0.24 |
MMSE % change |
|
|
|
Mean±SD |
7.3±46.9% |
5.9±27.4% |
0.89 |
Median |
0% |
0% |
0.56 |
HIS % change |
|
|
|
Mean±SD |
4.3±8.9% |
2.6±8.3% |
0.43 |
Median |
3.4% |
0% |
0.50 |